| 1 |
bladder cancer
(934 times)
|
Neoplasms
(321 times)
|
RC (112 times)
OS (69 times)
AUC (53 times)
|
2001 Structural alterations of sugar chains in urine fibronectin from bladder cancer patients and its enzymatic mechanism.
|
| 2 |
breast cancer
(478 times)
|
Neoplasms
(218 times)
|
ER (33 times)
PCa (25 times)
TNBC (19 times)
|
1997 A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
|
| 3 |
bias-corrected and accelerated
(22 times)
|
General Surgery
(4 times)
|
CI (4 times)
CIs (3 times)
AF (1 time)
|
2006 Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting.
|
| 4 |
breast carcinoma
(22 times)
|
Neoplasms
(8 times)
|
PR (6 times)
IHC (4 times)
ER (3 times)
|
1976 In vitro detection of cellular immunity to melanoma antigens in man by the monocyte spreading inhibition test.
|
| 5 |
bladder carcinoma
(13 times)
|
Neoplasms
(4 times)
|
ASODN (1 time)
BLCA (1 time)
CNTs (1 time)
|
2010 CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma.
|
| 6 |
bias-corrected and accelerated bootstrap
(4 times)
|
Cognitive Science
(1 time)
|
CI (1 time)
CIs (1 time)
GSCA (1 time)
|
2015 Simulation With PARTS (Phase-Augmented Research and Training Scenarios): A Structure Facilitating Research and Assessment in Simulation.
|
| 7 |
breast cancer cells
(2 times)
|
Metabolism
(1 time)
|
ESTA (1 time)
ESTA7 (1 time)
hOBM (1 time)
|
2013 Delineating breast cancer cell interactions with engineered bone microenvironments.
|
| 8 |
bias-corrected
(1 time)
|
Cardiology
(1 time)
|
CIs (1 time)
HF (1 time)
HRU (1 time)
|
2015 An economic evaluation of a self-care intervention in persons with heart failure and diabetes.
|
| 9 |
bias-corrected accelerated percentile interval
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2002 Bootstrap confidence levels for HIV-1 recombination.
|
| 10 |
bias-corrected percentile limits
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2005 Analysis of histamine release assays using the Bootstrap.
|
| 11 |
bladder cancer patients
(1 time)
|
Urology
(1 time)
|
APF (1 time)
CI (1 time)
MVA (1 time)
|
2019 How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection.
|
| 12 |
bladder cancer tissues
(1 time)
|
Cell Biology
(1 time)
|
lncRNAs (1 time)
|
2018 LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt/beta-catenin pathway by modulating miR-1275/AXIN2 axis.
|
| 13 |
breast cancer patients
(1 time)
|
Neoplasms
(1 time)
|
IL (1 time)
MCP-1 (1 time)
NN (1 time)
|
2007 Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
|
A Search Service for Abbreviation / Long Form